Navigation Links
Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
Date:11/19/2007

MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL) a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities, today announced that Randall A. Lipps, chairman, president & CEO and Rob Seim, vice president & CFO will present at the Piper Jaffray 19th Annual Health Care Conference at The Pierre Hotel, New York, NY. The Omnicell presentation is scheduled to begin at 12:00 p.m. on Wednesday, November 28, 2007.

A link to the audio-webcast of the live presentation may be accessed by visiting http://www.corporateir.net/ireye/conflobby.zhtml?ticker=OMCL&item_id=169622

Following the conference, a replay of the audio-webcast will be archived for 30 days on the site.

About Omnicell

Omnicell, Inc. (Nasdaq: OMCL) is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from large central pharmacy "smart inventory" carousels to small handheld devices. From the point at which a medication arrives at the receiving d
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
2. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
3. Omnicell Schedules Third Quarter Earnings Call
4. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
5. Omnicell Reports Strong Q3 Revenue and Profit Growth
6. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
7. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
8. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
9. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
10. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 The "area under the curve of oxygen ... approach to monitoring blood oxygen levels during procedures using ... & Analgesia . , The AUC Desat provides ... lowbut also on the depth, duration, and rate of ... Paul Niklewski, PhD, of University of Cincinnati and colleagues ...
(Date:9/23/2014)... the physical and mental health of girls and ... by researchers from the Institute for Reproductive Health ... effective strategies to change inequitable and harmful social ... Inequitable gender norms are not only related to ... as multiple sexual partners, smoking and alcohol abuse ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 The ... is now offering complimentary oral sedation with treatment for ... of Americans suffer from dental anxiety or dental phobia. ... patients; they can also keep patients from seeking desperately ... phobia in Westlake Village and surrounding areas now have ...
(Date:9/23/2014)... On September 23, 2014, My Positive Perspective founder Jason Deierlein ... the founder of Traveler of Charleston magazine and answered some ... At the start of the interview, Deierlein asked Simmons, “How ... replied by saying, “I had worked for the yellow pages ... and decided to start my own magazine thinking I could ...
(Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
Breaking Medicine News(10 mins):Health News:New measure provides more data on oxygen levels during sedation 2Health News:Safe passages into adulthood: Preventing gender-based violence and its consequences 2Health News:Safe passages into adulthood: Preventing gender-based violence and its consequences 3Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 2Health News:The Sedation Dental Office is Now Offering Complimentary Oral Sedation with Treatment for New Patients 3Health News:My Positive Perspective Airs Episode With the Founder of Traveler of Charleston Magazine 2Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2
... ... for small groups and business insurance premiums. Now, they are getting some answers and are ... , ... 3, 2009 -- The health care reform bills in being considered by the House, which ...
... , CHICAGO, July 2 Recent news reports have ... physicians meet high standards in their chosen area of ... (ABMS), which coordinates and assists its 24 Member Boards ... professional standards for the evaluation and certification of physician ...
... Dr Daniel Goldberg, a leading New Jersey ophthalmologist is ... 5% Betadine irrigation for treatment of acute EKC -- a ... with the potential for long term visual impairment due to ... invited to register to participate in the Betadine for EKC ...
... can help reduce threat, expert says , THURSDAY, ... threat to certain species of wildlife, which need to ... is one of the leading health concerns for humans, ... But we now understand that cancer can kill wild ...
... hepatitis B virus (HBV) are associated with the development of ... infections are at increased risk of the disease, according to ... Cancer Institute , published online July 2. HBV infection ... common form of liver cancer. Previous studies have looked at ...
... 2 American Scientific Resources, Inc. (Pink Sheets: ASFX), ... McWilliams, will be dedicating herself full-time to the position ... for Next One Interactive. , , Ms. ... Chief Financial Officer. She possesses in-depth, practical knowledge ...
Cached Medicine News:Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2Health News:Cancer Endangers Some Wildlife Species 2Health News:American Scientific Resources Announces Acting CFO Transition to Full-Time 2
(Date:9/23/2014)... , Sept. 23, 2014  Savant HWP, ... confirmed the initiation of human safety testing of ... addiction. A single dose of 18-MC, administered as ... conducted by Savant,s South American partner, was well ... Savant HWP plans to develop 18-MC as a ...
(Date:9/23/2014)... FRANCISCO , Sept. 23, 2014 Today, ... (ORS), announced the formation of the DripDrop Foundation, ... to preventable dehydration worldwide. Utilizing scientific advancements in ... introduce solutions to reduce dehydration and healthcare costs ... relief missions. "DripDrop has been ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... new additions to its Scientific Advisory Board.  The new ... Anthony Davies , PhD. Dr. Acker is ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3DripDrop Forms Foundation To Scale Relief Efforts 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7
... Nektar,Therapeutics (Nasdaq: NKTR ) today ... study,for NKTR-118 (PEG-naloxol), an oral treatment being ... clinical manifestations of,opioid-induced bowel dysfunction (OBD). The ... safety and tolerability,of NKTR-118 in patients experiencing ...
... Nastech Pharmaceutical,Company Inc. (Nasdaq: NSTK ) announced ... trial of PYY3-36 Nasal Spray to treat obesity. ... sites in the United States,for a six-month, randomized, ... evaluate three different doses of PYY3-36 Nasal Spray,compared ...
Cached Medicine Technology:Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 2Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 3Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 4Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction 5Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 2Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 3
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
... Liquichek Lipids Control is ... product that provides the ... analyte levels for lipids ... C-Reactive Protein in levels ...
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: